Scientists found antibodies that blocked the red-meat allergy in the lab.
42 antibodies made. Two blocked the reaction. In a dish, for now.
LAB BENCH HOPE.
Researchers generated 42 monoclonal antibodies against alpha-gal, the sugar behind alpha-gal syndrome — the tick-bite-triggered allergy to red meat. Thirteen bound allergens linked to the syndrome, two blocked patient IgE from attaching to certain allergens, and one interfered with basophil activation. NIH Research Matters reported the work on September 15, 2026; the study appeared in JCI on September 1 (DOI 10.1172/JCI192370).
WHAT HAPPENED
Alpha-gal syndrome starts with a tick bite and ends with people reacting to mammal products, sometimes hours after eating. The team built 42 antibodies that recognise the alpha-gal sugar and tested them against allergens associated with the syndrome. Thirteen bound. Two of those stopped antibodies from allergic patients' blood — IgE — from latching onto certain allergens, and one interfered with basophil activation, an early step in an allergic reaction. All of this happened in the laboratory. There is still no specific treatment or preventive: the advice remains avoiding tick bites and the foods that trigger you, and human studies would have to come next.
WHY THIS IS HOPESLOP
Most allergy news is about what you cannot eat. This is a group of people methodically looking for a molecule that could get in the way of the reaction itself. It is preclinical, it is not a treatment, and it may never become one. It is also the first plausible interference point anyone has shown for this particular strange, tick-delivered problem.
ORIGINAL SOURCENIHRead the original report
A DAILY ALLEGATION OF PROGRESS.
One good thing from the internet, every day. Nothing else.
MORE HOPESLOP
Three rehabilitated sea turtles became releases 497, 498 and 499 at a South Carolina aquarium.
Honey, Hope and Buffalo returned to the Atlantic after months of individualized care for fishhook injuries and related complications.
Sixteen percent of new U.S. utility-scale solar now arrives with battery storage.
That share was just 2% in 2017, and reported project plans put it above 30% for 2027 and 2028.
Barbados eliminated mother-to-child HIV transmission as a public-health problem.
An independent WHO assessment found no such infant infections from 2022 through 2024, with 98% coverage for care, testing and treatment.